| Hocena (antroquinonol) / Golden Biotechnology |
GHAML-2-001, NCT03823352: Evaluate Efficacy and Safety/Tolerability Profiles of Antroquinonol in Acute Myeloid Leukemia (AML) Adult Patients |
|
|
| Completed | 2a | 12 | RoW | Antroquinonol, Hocena | Golden Biotechnology Corporation | Leukemia, Myeloid, Acute | 12/20 | 12/20 | | |
NCT02719028: Trial of Antroquinonol in Patients With Hypercholesterolemia and Hyperlipidemia |
|
|
| Completed | 2 | 120 | RoW | Antroquinonol, Hocena 50mg, placebo | Golden Biotechnology Corporation | Hyperlipidemias | 09/18 | 03/19 | | |
NCT02047344: Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC |
|
|
| Completed | 2 | 31 | US, RoW | Antroquinonol, Hocena | Golden Biotechnology Corporation, ICON Clinical Research | Non-small Cell Lung Cancer Stage IV | 12/18 | 12/18 | | |
NCT04110873: A Phase II, Placebo-controlled Trial Evaluating the Efficacy of Antroquinonol in Patients With Atopic Dermatitis |
|
|
| Terminated | 2 | 14 | RoW | Antroquinonol Capsule 50mg, Antroquinonol 50mg, Antroquinonol Capsule 100mg, Antroquinonol 100mg, Placebo oral capsule, Placebo | Chung Shan Medical University, Golden Biotechnology Corporation | Atopic Dermatitis | 06/19 | 06/19 | | |
NCT03622463: A Trial of Antroquinonol in Patients With Atopic Dermatitis |
|
|
| Completed | 2 | 14 | RoW | Antroquinonol, Hocena, Placebo | Golden Biotechnology Corporation | Atopic Dermatitis | 07/19 | 07/19 | | |
NCT04112147: A Randomized, Placebo-controlled Trial of Antroquinonol in Patients With Chronic Hepatitis B |
|
|
| Unknown status | 2 | 60 | RoW | Antroquinonol capsule 100mg, Antroquinonol 100mg, Antroquinonol capsule 200mg, Antroquinonol 200mg, Placebo oral capsule, Placebo | Cheng-Chung Wei, Golden Biotechnology Corporation | Chronic Hepatitis B | 06/20 | 06/20 | | |
NCT04523181: Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients |
|
|
| Completed | 2 | 124 | US, RoW | Antroquinonol, Hocena, Placebo | Golden Biotechnology Corporation | Covid-19 | 12/21 | 12/21 | | |
NCT03625102: A Randomized, Double-Blind Trial of Antroquinonol in Patients With Chronic Hepatitis B |
|
|
| Completed | 2 | 60 | RoW | Antroquinonol, Hocena, placebo | Golden Biotechnology Corporation | HBV | 06/23 | 06/23 | | |
NCT03310632: Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer |
|
|
| Active, not recruiting | 1/2 | 52 | US, RoW | Antroquinonol, Hocena | Golden Biotechnology Corporation, Covance | Pancreatic Neoplasm | 11/23 | 03/24 | | |
